NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Contents
- Clinical guidelines update
- 1. Summary section
- 2. Evidence review and recommendations
- 3. References
- 4. Glossary and abbreviations
- Appendices
- Appendix A. Committee members and NICE teams
- Appendix B. Declaration of interests
- Appendix C. Review protocol
- Appendix D. Search strategy
- Appendix E. Review flowchart
- Appendix F. Excluded studies
- Appendix G. Evidence tables
- Appendix H. Modified GRADE profiles
- Appendix I. Economic search strategy
- Appendix J. Economic review flowchart
- Appendix K. Economic excluded studies
NICE clinical guideline CG30.1
This replaces Chapter 7: Progestogen-only subdermal implants (POSDIs) in clinical guideline 30
Commissioned by the National Institute for Health and Care Excellence
Disclaimer: Healthcare professionals are expected to take NICE clinical guidelines fully into account when exercising their clinical judgement. However, the guidance does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of each patient, in consultation with the patient and/or their guardian or carer.
- Addendum to Clinical Guideline 30, Long-acting reversible contraceptionAddendum to Clinical Guideline 30, Long-acting reversible contraception
Your browsing activity is empty.
Activity recording is turned off.
See more...